206 CSR 1
Senate Bill No. 441
(By Senators Minard, Fanning, Prezioso,
Unger, Boley and Facemyer)
__________
[Introduced January 25, 2008; referred to the
Committee on Health and Human Resources;
and then to the Committee on the Judiciary.]
__________
A BILL to amend and reenact article 9, chapter 64 of the Code of
West Virginia, 1931, as amended, relating to authorizing the
Office of the Pharmaceutical Advocate to promulgate a
legislative rule relating to prescription drug advertising
expense reporting.
Be it enacted by the Legislature of West Virginia:
That article 9, chapter 64 of the Code of West Virginia, 1931,
as amended, be amended and reenacted to read as follows:
ARTICLE 9. AUTHORIZATION FOR MISCELLANEOUS AGENCIES AND BOARDS TO
PROMULGATE LEGISLATIVE RULES.
§64-9-1. Office of the Pharmaceutical Advocate.
The legislative rule filed in the state register on the ninth
day of July, two thousand seven, authorized under the authority of
section thirteen, article three-c, chapter five-a, of this code,
modified by the Office of the Pharmaceutical Advocate to meet the
objections of the legislative rule-making review committee and
refiled in the state register on the fourteenth day of January, two
thousand eight, relating to the Office of the Pharmaceutical
Advocate (prescription drug advertising expense reporting, 206 CSR
1), is authorized.
NOTE: The purpose of this bill is to authorize the Office of
the Pharmaceutical Advocate to promulgate a legislative rule
relating to Prescription Drug Advertising Expense Reporting.
This section is new; therefore, strike-throughs and
underscoring have been omitted.